Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not?
Background: The new coronavirus outbreak quickly filled hospital beds and stunned the world. Intensive care is required for 5% of patients, and the mortality rate for critically ill patients is 49%. The “cytokine storm” is considered as the main cause of pathogenesis for coronavirus disease-19 (COVI...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Journal of Research in Medical Sciences |
| Subjects: | |
| Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=34;epage=34;aulast=Abbasi |
| _version_ | 1818436567918706688 |
|---|---|
| author | Saeed Abbasi Zohre Naderi Babak Amra Abdolamir Atapour Seyed Amir Dadkhahi Mohammad Javad Eslami Mohammad Reza Hajian Marzieh Hashemi Seyed Taghi Hashemi Bijan Iraj Farzin Khorvash Samane Madadi Hossein Mahjoubi Pour Marjan Mansourian Majid Rezvani Ramin Sami Forough Soltaninejad Shahrzad Shahidi Sahar Vahdat Zahra Zamani Firouzeh Moeinzadeh |
| author_facet | Saeed Abbasi Zohre Naderi Babak Amra Abdolamir Atapour Seyed Amir Dadkhahi Mohammad Javad Eslami Mohammad Reza Hajian Marzieh Hashemi Seyed Taghi Hashemi Bijan Iraj Farzin Khorvash Samane Madadi Hossein Mahjoubi Pour Marjan Mansourian Majid Rezvani Ramin Sami Forough Soltaninejad Shahrzad Shahidi Sahar Vahdat Zahra Zamani Firouzeh Moeinzadeh |
| author_sort | Saeed Abbasi |
| collection | DOAJ |
| description | Background: The new coronavirus outbreak quickly filled hospital beds and stunned the world. Intensive care is required for 5% of patients, and the mortality rate for critically ill patients is 49%. The “cytokine storm” is considered as the main cause of pathogenesis for coronavirus disease-19 (COVID-19)-related respiratory failure, hemoperfusion may be a modality for treatment of disease. Materials and Methods: Thirty-seven an patients with positive real-time polymerase chain reaction for SARStions2 in an upper respiratory tract sample or typical chest computed tomography lesion were eligible for this case–control study. Patients meeting the criteria for hemoperfusion including clinical and laboratory indices, were evaluated for outcomes such as hospitalization length and mortality. Patients were divided into three groups, i.e., patients who received hemoperfusion without a need for mechanical ventilation (MV), patients who received hemoperfusion before MV, and patients who received hemoperfusion after MV. Results: Among 37 patients with COVID-19 respiratory failure, 32% were female with a mean age of 55.54 (standard deviation 14.1) years. There was no statistically significant difference between the three groups in terms of length of hospital stay and intensive care unit (ICU) stay (P-tayns: 0.593 and 0.243, respectively, confidence interval [CI]: 95%). Heart rate, respiratory rate, PaO2/FIO2, high-sensitivity C-reactive protein, and ferritin significantly improved after the application of hemoperfusion in all groups (P < 0.05, CI: 95%). Conclusion: It seems that applying hemoperfusion in the inflammatory phase of the disease, especially before the intubation, reduce the need for MV. However, hemoperfusion does not have any impacts on the duration of hospital and ICU stay. |
| first_indexed | 2024-12-14T17:10:50Z |
| format | Article |
| id | doaj.art-5bfcf6bc957a4c68a35101295a326f55 |
| institution | Directory Open Access Journal |
| issn | 1735-1995 1735-7136 |
| language | English |
| last_indexed | 2024-12-14T17:10:50Z |
| publishDate | 2021-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Research in Medical Sciences |
| spelling | doaj.art-5bfcf6bc957a4c68a35101295a326f552022-12-21T22:53:34ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362021-01-01261343410.4103/jrms.JRMS_1122_20Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not?Saeed AbbasiZohre NaderiBabak AmraAbdolamir AtapourSeyed Amir DadkhahiMohammad Javad EslamiMohammad Reza HajianMarzieh HashemiSeyed Taghi HashemiBijan IrajFarzin KhorvashSamane MadadiHossein Mahjoubi PourMarjan MansourianMajid RezvaniRamin SamiForough SoltaninejadShahrzad ShahidiSahar VahdatZahra ZamaniFirouzeh MoeinzadehBackground: The new coronavirus outbreak quickly filled hospital beds and stunned the world. Intensive care is required for 5% of patients, and the mortality rate for critically ill patients is 49%. The “cytokine storm” is considered as the main cause of pathogenesis for coronavirus disease-19 (COVID-19)-related respiratory failure, hemoperfusion may be a modality for treatment of disease. Materials and Methods: Thirty-seven an patients with positive real-time polymerase chain reaction for SARStions2 in an upper respiratory tract sample or typical chest computed tomography lesion were eligible for this case–control study. Patients meeting the criteria for hemoperfusion including clinical and laboratory indices, were evaluated for outcomes such as hospitalization length and mortality. Patients were divided into three groups, i.e., patients who received hemoperfusion without a need for mechanical ventilation (MV), patients who received hemoperfusion before MV, and patients who received hemoperfusion after MV. Results: Among 37 patients with COVID-19 respiratory failure, 32% were female with a mean age of 55.54 (standard deviation 14.1) years. There was no statistically significant difference between the three groups in terms of length of hospital stay and intensive care unit (ICU) stay (P-tayns: 0.593 and 0.243, respectively, confidence interval [CI]: 95%). Heart rate, respiratory rate, PaO2/FIO2, high-sensitivity C-reactive protein, and ferritin significantly improved after the application of hemoperfusion in all groups (P < 0.05, CI: 95%). Conclusion: It seems that applying hemoperfusion in the inflammatory phase of the disease, especially before the intubation, reduce the need for MV. However, hemoperfusion does not have any impacts on the duration of hospital and ICU stay.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=34;epage=34;aulast=Abbasicovid-19hemoperfusionrespiratory failure |
| spellingShingle | Saeed Abbasi Zohre Naderi Babak Amra Abdolamir Atapour Seyed Amir Dadkhahi Mohammad Javad Eslami Mohammad Reza Hajian Marzieh Hashemi Seyed Taghi Hashemi Bijan Iraj Farzin Khorvash Samane Madadi Hossein Mahjoubi Pour Marjan Mansourian Majid Rezvani Ramin Sami Forough Soltaninejad Shahrzad Shahidi Sahar Vahdat Zahra Zamani Firouzeh Moeinzadeh Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not? Journal of Research in Medical Sciences covid-19 hemoperfusion respiratory failure |
| title | Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not? |
| title_full | Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not? |
| title_fullStr | Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not? |
| title_full_unstemmed | Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not? |
| title_short | Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not? |
| title_sort | hemoperfusion in patients with severe covid 19 respiratory failure lifesaving or not |
| topic | covid-19 hemoperfusion respiratory failure |
| url | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=34;epage=34;aulast=Abbasi |
| work_keys_str_mv | AT saeedabbasi hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT zohrenaderi hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT babakamra hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT abdolamiratapour hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT seyedamirdadkhahi hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT mohammadjavadeslami hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT mohammadrezahajian hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT marziehhashemi hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT seyedtaghihashemi hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT bijaniraj hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT farzinkhorvash hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT samanemadadi hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT hosseinmahjoubipour hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT marjanmansourian hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT majidrezvani hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT raminsami hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT foroughsoltaninejad hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT shahrzadshahidi hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT saharvahdat hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT zahrazamani hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot AT firouzehmoeinzadeh hemoperfusioninpatientswithseverecovid19respiratoryfailurelifesavingornot |